| Dr Eric Robert Carson, OD | |
|
235 Washington St., Suite #1, Saratoga Springs, NY 12866-5963 | |
| (518) 587-5900 | |
| (518) 587-5938 |
| Full Name | Dr Eric Robert Carson |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 42 Years |
| Location | 235 Washington St., Saratoga Springs, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407891476 | NPI | - | NPPES |
| 00719824 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TUV 004102 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Buenaus Opticians Inc | 1355484346 | 3 |
| Saratoga Optometric Assoc, Pc | 5294821724 | 7 |
News Archive
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended.
A small study published in the journal JCI Insight on November 14, 2019, suggests that antibody treatment could help people with severe allergy to peanuts eat a small amount of peanut-containing food just two weeks later, without any ill effects. This seems to show that this is a safe, fast and effective treatment for food allergy.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
A new drug appears to offer pain relief and increased mobility to rheumatoid arthritis patients who have exhausted their other medical treatment options.
› Verified 7 days ago
| Provider Name | Saratoga Optometric Assoc, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942344148 PECOS PAC ID: 5294821724 Enrollment ID: O20071015000446 |
News Archive
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended.
A small study published in the journal JCI Insight on November 14, 2019, suggests that antibody treatment could help people with severe allergy to peanuts eat a small amount of peanut-containing food just two weeks later, without any ill effects. This seems to show that this is a safe, fast and effective treatment for food allergy.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
A new drug appears to offer pain relief and increased mobility to rheumatoid arthritis patients who have exhausted their other medical treatment options.
› Verified 7 days ago
| Provider Name | Buenaus Opticians Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659425650 PECOS PAC ID: 1355484346 Enrollment ID: O20100129000229 |
News Archive
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended.
A small study published in the journal JCI Insight on November 14, 2019, suggests that antibody treatment could help people with severe allergy to peanuts eat a small amount of peanut-containing food just two weeks later, without any ill effects. This seems to show that this is a safe, fast and effective treatment for food allergy.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
A new drug appears to offer pain relief and increased mobility to rheumatoid arthritis patients who have exhausted their other medical treatment options.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Robert Carson, OD 235 Washington St., Suite #1, Saratoga Springs, NY 12866-5963 Ph: (518) 587-5900 | Dr Eric Robert Carson, OD 235 Washington St., Suite #1, Saratoga Springs, NY 12866-5963 Ph: (518) 587-5900 |
News Archive
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc. The tender offer expired at 12:00 midnight ET, at the end of November 5, 2009, and was not extended.
A small study published in the journal JCI Insight on November 14, 2019, suggests that antibody treatment could help people with severe allergy to peanuts eat a small amount of peanut-containing food just two weeks later, without any ill effects. This seems to show that this is a safe, fast and effective treatment for food allergy.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
A new drug appears to offer pain relief and increased mobility to rheumatoid arthritis patients who have exhausted their other medical treatment options.
› Verified 7 days ago
Family Vision Care Center Optometrist Medicare: Medicare Enrolled Practice Location: 205 Lake Ave, Saratoga Springs, NY 12866 Phone: 518-584-6111 Fax: 518-580-8589 | |
Dr. David I Garfinkel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: Wilson Square 3039 Route 50, Empire Vision Centers, Saratoga Springs, NY 12866 Phone: 518-580-1117 Fax: 518-580-1311 | |
Kimberly A Dobrodziej, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 206 Lake Ave, Saratoga Springs, NY 12866 Phone: 518-584-2620 Fax: 518-584-3979 | |
Dr. Tochuku C Nkadi, O.D, M.S Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3039 Route # 50, Empire Vision Centers, Saratoga Springs, NY 12866 Phone: 518-580-1117 Fax: 518-580-1311 | |
Punit Jain, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3065 Route 50, Saratoga Springs, NY 12866 Phone: 518-583-0202 | |
Dr. Meghan Elizabeth Brown, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 235 Washington St, Saratoga Springs, NY 12866 Phone: 518-587-5900 | |
Dr. Brenda Marie Dobie, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 414 Maple Ave, Saratoga Springs, NY 12866 Phone: 518-587-2020 Fax: 518-587-2027 |